Middle East Pharmaceutical Industries Co

SAU:4016Healthcaretasi

SAR 62.40+0.32%At closeAt close · Mon 19 Oct · ≈ AED 61.11 · Market cap $582.4M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	56.9%	58.9%	58.7%	61.2%	61.8%	62.3%	—	—
Operating margin	26.9%	26.6%	23.2%	23.1%	23.1%	23.5%	23.5%	+0.0 pts
Net margin	24.1%	23.1%	19.6%	19.5%	20.3%	21.1%	21.1%	+0.0 pts
EBITDA margin	29.6%	28.9%	26.8%	25.2%	27.1%	27.9%	—	—
Return on equity	28.8%	24.8%	21.2%	21.5%	21.7%	23.3%	23.3%	+0.0 pts
Return on assets	19.6%	15.9%	13.4%	14.8%	15.2%	16.2%	16.2%	+0.0 pts
Return on capital employed	28.4%	25.5%	22.6%	23.6%	23.2%	23.2%	—	—
Debt / equity	0.2×	0.3×	0.3×	0.2×	0.2×	0.2×	0.2×	+0.0%
Debt / assets	16.9%	20.9%	19.2%	13.4%	12.4%	10.6%	—	—
Interest coverage	30.2×	26.0×	12.1×	11.2×	24.8×	23.2×	—	—
Current ratio	2.7×	2.3×	2.2×	2.5×	2.7×	3.1×	3.1×	+0.0%
Quick ratio	1.6×	1.6×	1.4×	1.7×	2.0×	2.3×	—	—
Cash ratio	0.2×	0.2×	0.2×	0.1×	0.2×	0.3×	0.3×	+0.0%
Asset turnover	0.8×	0.7×	0.7×	0.8×	0.7×	0.8×	—	—
Inventory turnover	1.4×	1.5×	1.2×	1.5×	1.6×	1.7×	—	—
Receivables turnover	2.7×	1.7×	1.9×	2.2×	1.8×	1.8×	—	—
Dividend payout	49.8%	56.1%	61.1%	54.7%	18.8%	48.4%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.